Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBIAT (2016 - 2018)

Historic EBIAT for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$1.1 million.

  • Armata Pharmaceuticals' EBIAT rose 5318.88% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$9.4 million, marking a year-over-year increase of 2685.0%. This contributed to the annual value of -$18.9 million for FY2024, which is 7260.34% up from last year.
  • According to the latest figures from Q4 2018, Armata Pharmaceuticals' EBIAT is -$1.1 million, which was up 5318.88% from -$2.8 million recorded in Q3 2018.
  • Armata Pharmaceuticals' EBIAT's 5-year high stood at $21.2 million during Q3 2014, with a 5-year trough of -$14.5 million in Q1 2015.
  • In the last 5 years, Armata Pharmaceuticals' EBIAT had a median value of -$2.4 million in 2016 and averaged -$848526.3.
  • Data for Armata Pharmaceuticals' EBIAT shows a peak YoY increase of 19474.15% (in 2014) and a maximum YoY decrease of 58735.56% (in 2014) over the last 5 years.
  • Armata Pharmaceuticals' EBIAT (Quarter) stood at -$664000.0 in 2014, then plummeted by 235.99% to -$2.2 million in 2015, then plummeted by 325.82% to -$9.5 million in 2016, then soared by 75.24% to -$2.4 million in 2017, then skyrocketed by 53.19% to -$1.1 million in 2018.
  • Its EBIAT stands at -$1.1 million for Q4 2018, versus -$2.8 million for Q3 2018 and -$3.2 million for Q2 2018.